$0.5193
-0.05-9.15%
At close: -
$0.5300
0.012.06%
After Hours: 7:55 PM EDT
Leap Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Leap Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.44 | $-0.48 | 8.33 % |
Q2 | 2024-08-12 | $-0.52 | $-0.43 | -20.9 % |
Q1 | 2024-05-13 | $-0.51 | $-0.58 | 12.1 % |
Q4 | 2024-03-18 | $-0.46 | $-0.55 | 16.4 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2023-03-24 | $0 | $1.20M | -100.0 % |
Q2 | 2022-08-12 | $0 | $80.00K | -100.0 % |
Q4 | 2022-03-11 | $375.00K | $310.00K | 21.0 % |
Q3 | 2021-11-12 | $375.00K | $1.51M | -75.2 % |
Leap Therapeutics (LPTX) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.44, which beat the estimate of $-0.48.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.